Synaptics, Inc.

As of August 7, 2025, Synaptics, Inc. is considered a risky investment due to its overvaluation indicated by a P/E ratio of 19, poor performance with a YTD return of -2.58% compared to the S&P 500's 12.22%, and a significant 3-year return of -31.11% versus the index's 70.41%.

As of May 8, 2025, Synaptics, Inc. is considered attractive but overvalued with a P/E ratio of 19 and an EV to EBITDA of 60.31, showing lower growth expectations compared to peers, and has underperformed the S&P 500 with a year-to-date decline of 16.71%.

As of June 2, 2025, Synaptics, Inc. shows a mildly bearish trend due to daily moving averages indicating bearish sentiment, despite some weekly indicators suggesting mild bullishness, resulting in mixed signals overall.

As of March 2022, the management team of Synaptics, Inc. includes Independent Chairman Mr. Nelson Chan, CEO Mr. Michael Hurlston, and several Independent Directors: Ms. Kiva Allgood, Mr. Jeffrey Buchanan, Mr. Keith Geeslin, Ms. Susan Hardman, and Mr. James Whims. They are responsible for the company's strategic direction and governance.

Synaptics, Inc. develops and sells human interface solutions for electronic devices, classified as a mid-cap company with a market cap of approximately $4.2 billion. As of March 2025, it reported net sales of $267 million and a net profit of -$22 million.

As of Jun 18, Synaptics, Inc. has a market capitalization of $4.20 billion, with net sales of $1.04 billion and a net profit of $165.20 million reported over the latest four quarters.